South African API case could involve Rand10 billion
This article was originally published in Scrip
Executive Summary
About 200 investors may have lost up to Rand10 billion ($1.24 billion) in a South African active pharmaceutical ingredient (API) business, which allegedly falsified purchase orders from major pharmaceutical companies in order to gain both their confidence and money.